Cargando…

Cathepsin D: A Candidate Link between Amyloid β-protein and Tauopathy in Alzheimer Disease

Alzheimer disease (AD) is a debilitating neurodegenerative disorder characterized by extracellular deposition of the amyloid β-protein (Aβ) and intraneuronal accumulation of the microtubule-associated protein, tau. Despite a wealth of experimental and genetic evidence implicating both Aβ and tau in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suire, Caitlin N., Leissring, Malcolm A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929084/ https://www.ncbi.nlm.nih.gov/pubmed/33665647

Ejemplares similares

Prominent tauopathy and intracellular β-amyloid accumulation triggered by genetic deletion of cathepsin D: Implications for Alzheimer disease pathogenesis
por: Terron, Heather M., et al.
Publicado: (2023)

Cathepsin D regulates cerebral Aβ42/40 ratios via differential degradation of Aβ42 and Aβ40
por: Suire, Caitlin N., et al.
Publicado: (2020)

Regulation of distinct pools of amyloid β-protein by multiple cellular proteases
por: Leissring, Malcolm A, et al.
Publicado: (2013)

Quantitative, High-Throughput Assays for Proteolytic Degradation of Amylin
por: Suire, Caitlin N., et al.
Publicado: (2020)

Cognitive Decline in Preclinical Alzheimer’s Disease: Amyloid-Beta versus Tauopathy
por: Huber, Colin M., et al.
Publicado: (2017)

Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer’s disease
por: Hanseeuw, Bernard J., et al.
Publicado: (2019)

The Link Between Tau and Insulin Signaling: Implications for Alzheimer’s Disease and Other Tauopathies
por: Gonçalves, Rafaella Araujo, et al.
Publicado: (2019)

Heterogeneous Association of Alzheimer’s Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses
por: Willén, Katarina, et al.
Publicado: (2017)

Amyloid and Tau Positron Emission Tomography Imaging in Alzheimer’s Disease and Other Tauopathies
por: Maschio, Cinzia, et al.
Publicado: (2022)

Microglial cathepsin E plays a role in neuroinflammation and amyloid β production in Alzheimer’s disease
por: Xie, Zhen, et al.
Publicado: (2022)

A Dual-Function “TRE-Lox” System for Genetic Deletion or Reversible, Titratable, and Near-Complete Downregulation of Cathepsin D
por: Terron, Heather M., et al.
Publicado: (2023)

Aβ degradation—the inside story
por: Leissring, Malcolm A.
Publicado: (2014)

Targeting Insulin-Degrading Enzyme in Insulin Clearance
por: Leissring, Malcolm A., et al.
Publicado: (2021)

Untangling the Tauopathy for Alzheimer’s disease and parkinsonism
por: Chang, Hui-Yun, et al.
Publicado: (2018)

ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's Disease
por: Letronne, Florent, et al.
Publicado: (2016)

Amyloid β-protein oligomers and Alzheimer’s disease
por: Hayden, Eric Y, et al.
Publicado: (2013)

Increased tauopathy drives microglia-mediated clearance of beta-amyloid
por: Chen, Wesley, et al.
Publicado: (2016)

Ion Channel Formation by Tau Protein: Implications for Alzheimer’s Disease and Tauopathies
por: Patel, Nirav, et al.
Publicado: (2015)

Tau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies
por: Sinsky, Jakub, et al.
Publicado: (2021)

Lipid rafts: linking prion protein to zinc transport and amyloid-β toxicity in Alzheimer's disease
por: Watt, Nicole T., et al.
Publicado: (2014)

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
por: Rawat, Priyanka, et al.
Publicado: (2022)

Neuroimmune proteins can differentiate between tauopathies
por: Cherry, Jonathan D., et al.
Publicado: (2022)

Seizures are a druggable mechanistic link between TBI and subsequent tauopathy
por: Alyenbaawi, Hadeel, et al.
Publicado: (2021)

DNA Methylation in Genetic and Sporadic Forms of Neurodegeneration: Lessons from Alzheimer’s, Related Tauopathies and Genetic Tauopathies
por: Zimmer-Bensch, Geraldine, et al.
Publicado: (2021)

Identification of Cathepsin D as a Plasma Biomarker for Alzheimer’s Disease
por: Kim, Jae-Whan, et al.
Publicado: (2021)

Identification of BACE2 as an avid ß-amyloid-degrading protease
por: Abdul-Hay, Samer O, et al.
Publicado: (2012)

ApoE4 lowers age at onset in patients with frontotemporal dementia and tauopathy independent of amyloid-β copathology
por: Koriath, Carolin, et al.
Publicado: (2019)

Alzheimer's Disease Amyloid-β Links Lens and Brain Pathology in Down Syndrome
por: Moncaster, Juliet A., et al.
Publicado: (2010)

PET Imaging of Tau Pathology in Alzheimer’s Disease and Tauopathies
por: James, Olga G., et al.
Publicado: (2015)

Prospects for strain-specific immunotherapy in Alzheimer’s disease and tauopathies
por: Bittar, Alice, et al.
Publicado: (2018)

Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
por: Laurent, Cyril, et al.
Publicado: (2018)

Effects of Deferasirox in Alzheimer’s Disease and Tauopathy Animal Models
por: Kwan, Ping, et al.
Publicado: (2022)

Type-I Interferons in Alzheimer's Disease and Other Tauopathies
por: Sanford, Sophie A. I., et al.
Publicado: (2022)

Brain-Penetrant, Orally Bioavailable Microtubule-Stabilizing Small Molecules Are Potential Candidate Therapeutics for Alzheimer’s Disease and Related Tauopathies
por: Lou, Kevin, et al.
Publicado: (2014)

Case report: Non-Alzheimer's disease tauopathy with logopenic variant primary progressive aphasia diagnosed using amyloid and tau PET
por: Momota, Yuki, et al.
Publicado: (2022)

Cathepsin B Deficiency Improves Memory Deficits and Reduces Amyloid-β in hAβPP Mouse Models Representing the Major Sporadic Alzheimer’s Disease Condition
por: Hook, Gregory, et al.
Publicado: (2023)

Nontoxic singlet oxygen generator as a therapeutic candidate for treating tauopathies
por: Sheik Mohideen, Sahabudeen, et al.
Publicado: (2015)

Stabilization of Monomeric Tau Protein by All D-Enantiomeric Peptide Ligands as Therapeutic Strategy for Alzheimer’s Disease and Other Tauopathies
por: Altendorf, Tim, et al.
Publicado: (2023)

Interactions between Amyloid-β and Hemoglobin: Implications for Amyloid Plaque Formation in Alzheimer's Disease
por: Chuang, Jia-Ying, et al.
Publicado: (2012)

Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies
por: Šimić, Goran, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ot1uci5bsihf8qhd7d30cel0jc